{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:35:07Z","timestamp":1789799707099,"version":"4.0.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Disseminated mucormycosis, a serious complication, is associated with high mortality in patients with acute leukemia after chemotherapy. Blood cultures are always negative because of recurrent empirical antifungal treatments. The identification of pathogens is important for diagnosis and therapy. In this case report, we diagnosed culture-negative disseminated mucormycosis with <jats:italic>Rhizomucor miehei<\/jats:italic> infection leading to cerebral infarction in a patient with leukemia using metagenomics next-generation sequencing (mNGS) form peripheral blood, cerebral spinal fluid, and bronchoalveolar lavage fluid. mNGS technology can be applied to precisely diagnose culture-negative disseminated mucormycosis.<\/jats:p>","DOI":"10.3389\/fmed.2021.779981","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T07:11:46Z","timestamp":1639725106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Case Report: Metagenomics Next-Generation Sequencing for Diagnosing Cerebral Infarction and Infection Caused by Hematogenous Disseminated Mucormycosis in a Patient With Acute Lymphoblastic Leukemia"],"prefix":"10.3389","volume":"8","author":[{"given":"Bingbing","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11908-007-0066-4","article-title":"Zygomycosis: an emerging fungal infection with new options for management","volume":"9","author":"Kauffman","year":"2007","journal-title":"Curr Infect Dis Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Internal Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1128\/JCM.44.3.805-810.2006","article-title":"Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism","volume":"44","author":"Machouart","year":"2006","journal-title":"J Clin Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/JCM.00256-11","article-title":"Molecular methods to improve diagnosis and identification of mucormycosis","volume":"49","author":"Hammond","year":"2011","journal-title":"J Clin Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"ofaa552","DOI":"10.1093\/ofid\/ofaa552","article-title":"Isolated cerebral mucormycosis in immunocompetent adults who inject drugs: case reports and systematic review of the literature","volume":"7","author":"Meyerowitz","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2141.2004.05080.x","article-title":"Cerebral mucormycosis in a patient with myelodysplastic syndrome taking corticosteroids","volume":"126","author":"Droll","year":"2004","journal-title":"Br J Haematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/fmb.14.23","article-title":"Laboratory diagnosis of mucormycosis: current status and future perspectives","volume":"9","author":"Lackner","year":"2014","journal-title":"Fut Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.amjmed.2015.08.033","article-title":"A cryptic case: isolated cerebral mucormycosis","volume":"128","author":"Dhakar","year":"2015","journal-title":"Am J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"872e871","DOI":"10.1016\/j.wneu.2016.11.130","article-title":"Affinity of mucormycosis for basal ganglia in intravenous drug users: case illustration and review of literature","volume":"98","author":"Hazama","year":"2017","journal-title":"World Neurosurg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.wneu.2018.10.218","article-title":"Diagnosis and treatment of isolated cerebral mucormycosis: patient-level data meta-analysis and mayo clinic experience","volume":"123","author":"Kerezoudis","year":"2019","journal-title":"World Neurosurg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"A clinical metagenomics nature reviews","volume":"20","author":"Chiu","year":"2019","journal-title":"Genetics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13656","DOI":"10.1111\/tid.13656","article-title":"Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA","volume":"23","author":"Martin-Blais","year":"2021","journal-title":"Trans Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"682758","DOI":"10.3389\/fmed.2021.682758","article-title":"Case report: diagnostic value of metagenomics next generation sequencing in intracranial infection caused by Mucor","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med."},{"key":"B18","first-page":"13639","article-title":"Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia","volume":"8","author":"Higo","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s150100070047","article-title":"Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis","volume":"28","author":"Eucker","year":"2000","journal-title":"Infection."},{"key":"B20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2141.1997.3983214.x","article-title":"Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases","volume":"99","author":"Pagano","year":"1997","journal-title":"Br J Haematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/clinids\/19.3.402","article-title":"Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992","volume":"19","author":"Hagensee","year":"1994","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/ajcp\/77.1.110","article-title":"Disseminated mucormycosis in a case of metastatic carcinoma","volume":"77","author":"El-Ani","year":"1982","journal-title":"Am J Clin Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/BF02185855","article-title":"Fungal blood cultures","volume":"8","author":"Telenti","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2141.1995.tb08355.x","article-title":"Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto)","volume":"89","author":"Pagano","year":"1995","journal-title":"Br J Haematol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1200\/JCO.1999.17.3.796","article-title":"Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography","volume":"17","author":"Heussel","year":"1999","journal-title":"J Clin Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2214\/ajr.168.6.9168721","article-title":"Pulmonary mucormycosis: radiologic findings in 32 cases","volume":"168","author":"McAdams","year":"1997","journal-title":"AJR"},{"key":"B27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jmoldx.2015.07.004","article-title":"A next-generation sequencing for infectious disease diagnosis and management: a report of the association for molecular pathology","volume":"17","author":"Lefterova","year":"2015","journal-title":"J Molec Diagnost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmi.2017.10.013","article-title":"Next-generation sequencing technologies and their application to the study and control of bacterial infections","volume":"24","author":"Besser","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1093\/cid\/ciy693","article-title":"Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice","volume":"67","author":"Miao","year":"2018","journal-title":"Clin Infec Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infec Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T07:11:49Z","timestamp":1639725109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":30,"alternative-id":["10.3389\/fmed.2021.779981"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.779981","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"article-number":"779981"}}